SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-252121
Filing Date
2017-08-09
Accepted
2017-08-09 08:08:52
Documents
48
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d430927d10q.htm 10-Q 555434
2 EX-31.1 d430927dex311.htm EX-31.1 9335
3 EX-31.2 d430927dex312.htm EX-31.2 9304
4 EX-32.1 d430927dex321.htm EX-32.1 5089
  Complete submission text file 0001193125-17-252121.txt   2313937

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ardx-20170630.xml EX-101.INS 394962
6 XBRL TAXONOMY EXTENSION SCHEMA ardx-20170630.xsd EX-101.SCH 26206
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ardx-20170630_cal.xml EX-101.CAL 45448
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ardx-20170630_def.xml EX-101.DEF 66822
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ardx-20170630_lab.xml EX-101.LAB 201186
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ardx-20170630_pre.xml EX-101.PRE 137602
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 171016499
SIC: 2834 Pharmaceutical Preparations